4566 related articles for article (PubMed ID: 3669927)
1. Lipid composition of cultured B16 melanoma cell variants with different lung-colonizing potential.
Calorini L; Fallani A; Tombaccini D; Mugnai G; Ruggieri S
Lipids; 1987 Sep; 22(9):651-6. PubMed ID: 3669927
[TBL] [Abstract][Full Text] [Related]
2. Prolonged in vitro culture modifies the surface lipid composition of murine melanoma cell lines.
Moretti S; Montorfano G; Rapelli S; Berra B
Ital J Biochem; 1998 Mar; 47(1):19-27. PubMed ID: 9646186
[TBL] [Abstract][Full Text] [Related]
3. Prolonged in vitro culture modifies the surface lipid composition of murine melanoma cell lines.
Moretti S; Montorfano G; Rapelli S; Berra B
Ital J Biochem; 1997 Dec; 46(4):187-94. PubMed ID: 9541865
[TBL] [Abstract][Full Text] [Related]
4. Characterization of mouse melanoma cell lines by their mortal malignancy using an experimental metastatic model.
Nakamura K; Yoshikawa N; Yamaguchi Y; Kagota S; Shinozuka K; Kunitomo M
Life Sci; 2002 Jan; 70(7):791-8. PubMed ID: 11833741
[TBL] [Abstract][Full Text] [Related]
5. Membrane lipids and enzymes of cultured high- and low-metastatic B16 melanoma variants.
Schroeder F; Gardiner JM
Cancer Res; 1984 Aug; 44(8):3262-9. PubMed ID: 6146400
[TBL] [Abstract][Full Text] [Related]
6. Suppression of B16 melanoma lung colonization by syngeneic monoclonal antibodies.
Herd ZL
Cancer Res; 1987 May; 47(10):2696-703. PubMed ID: 3552203
[TBL] [Abstract][Full Text] [Related]
7. Characterization of plasma membrane shedding from murine melanoma cells.
Taylor DD; Taylor CG; Jiang CG; Black PH
Int J Cancer; 1988 Apr; 41(4):629-35. PubMed ID: 3356493
[TBL] [Abstract][Full Text] [Related]
8. Metastatic potential of murine B16 melanoma correlates with reduced surface heparan sulfate glycosaminoglycan.
Kure S; Yoshie O; Aso H
Jpn J Cancer Res; 1987 Nov; 78(11):1238-45. PubMed ID: 2961717
[TBL] [Abstract][Full Text] [Related]
9. Extraction of immunogenic and suppressogenic antigens from variants of B16 melanoma exhibiting low or high metastatic potentials.
LeGrue SJ; Hearn DR
Cancer Res; 1983 Nov; 43(11):5106-11. PubMed ID: 6616449
[TBL] [Abstract][Full Text] [Related]
10. Differences in cell density associated with differences in lung-colonizing ability of B16 melanoma cells.
Baniyash M; Netanel T; Witz IP
Cancer Res; 1981 Feb; 41(2):433-7. PubMed ID: 7448787
[TBL] [Abstract][Full Text] [Related]
11. Expression of tumor antigen correlated with metastatic potential of Lewis lung carcinoma and B16 melanoma clones in mice.
Falcioni R; Kennel SJ; Giacomini P; Zupi G; Sacchi A
Cancer Res; 1986 Nov; 46(11):5772-8. PubMed ID: 3756921
[TBL] [Abstract][Full Text] [Related]
12. Differential cell- and immuno-biological properties of murine B16-F1 and F10 melanomas: oncogene c-fos expression, sensitivity to LAK cells and/or IL-2, and components of gangliosides.
Nakayama J; Urabe K; Tsuchida T; Urabe A; Terao H; Taniguchi S; Hori Y
J Dermatol; 1995 Aug; 22(8):549-59. PubMed ID: 7560451
[TBL] [Abstract][Full Text] [Related]
13. Phospholipid composition, phosphoinositide metabolism and metastatic capacity in murine melanoma B16 variants at different stages of growth.
Lligona Trulla L; Magistrelli A; Salmona M; Tacconi MT
Melanoma Res; 1992 Nov; 2(4):235-40. PubMed ID: 1337002
[TBL] [Abstract][Full Text] [Related]
14. Differences in lipid characteristics of autologous human melanoma cell lines with distinct biological properties.
Le Bivic A; Sari H; Reynier M; Lebec S; Bardin F
J Natl Cancer Inst; 1987 Dec; 79(6):1181-8. PubMed ID: 3480369
[TBL] [Abstract][Full Text] [Related]
15. Enhanced metastasis of B16 melanoma cells by unexpected elevated expression of the metastasis-associated TI-241 (LRF-1-, Jun-Fos-related) gene treated with antisense oligonucleotide.
Ishiguro T; Naito M; Hanaoka K; Nagawa H; Muto T; Tsuruo T
Clin Exp Metastasis; 1998 Feb; 16(2):179-83. PubMed ID: 9514099
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effect of tripeptide compound tyroservaltide on invasion and metastasis of mouse melanoma cell line B16-F10].
Che XC; Lu R; Hu JX; Zheng MN; Zhang MF; Wang S; Yu CY; Yang XL; Xing DH; Yao Z
Ai Zheng; 2006 Mar; 25(3):275-80. PubMed ID: 16536978
[TBL] [Abstract][Full Text] [Related]
17. Lipid composition of human malignant melanoma tumors at various levels of malignant growth.
Portoukalian J; Zwingelstein G; Doré JF
Eur J Biochem; 1979 Feb; 94(1):19-23. PubMed ID: 436839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by tyroserleutide (YSL) on the invasion and adhesion of the mouse melanoma cell.
Yao Z; Che XC; Lu R; Zheng MN; Zhu ZF; Li JP; Jian X; Shi LX; Liu JY; Gao WY
Mol Med; 2007; 13(1-2):14-21. PubMed ID: 17515953
[TBL] [Abstract][Full Text] [Related]
19. Interaction of tumor and surrounding tissue of mice inoculated B16 melanoma variants in terms of enzyme activity.
Nakao H; Takamori K; Ogawa H
Int J Biochem; 1989; 21(7):739-43. PubMed ID: 2668066
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of sialidase activity and G(M3) content in B16 melanoma variants with different metastatic potential.
Sawada M; Moriya S; Shineha R; Satomi S; Miyagi T
Acta Biochim Pol; 1998; 45(2):343-9. PubMed ID: 9821865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
